Clozapine Offers New Possibilities for Treatment-Resistant Schizophrenia
mNGS Proves Economically Viable for CNS Infections in Post-Op Critical Care
Global Bisphenol Crisis: Surging Health Costs Exceed Trillion-Dollar Mark
Medicare Drug Pricing to Face Major Policy Shakeup in 2028
Glove Change Strategy in C-Section Reduces Infections and Saves Costs
New Insights into Risk Adjustment Gaps in Health Insurance for New Chronic Diseases
Osimertinib Proves Cost-Effective for Stage III EGFR-Mutated NSCLC in China
Resource Allocation in China’s Healthcare System: A Shift in Patient Dynamics
Innovative mHealth Tool Aims to Tackle Rising Dementia Cases in Peru
Understanding the Dynamics of Medicare Diagnosis Coding Practices
A New Strategy to Fight Cardiovascular Disease: Evaluating FH Screening’s Costs and Benefits
New Insights in Treating Moderate Basal Ganglia Hemorrhage Using Modern Techniques
Checkpoint Inhibitor Pricing Faces Minimal Decline Despite Market Saturation
CMS Pioneers New Drug Pricing Model for Medicaid Benefits


